Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

NCT01320176 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: Investigational HIV vaccine dose A
BIOLOGICAL: Investigational HIV vaccine dose B

Sponsor

Institut Pasteur